Weller K, Staubach P, Metz M, Chapman-Rothe N, Sieder C, Brautigam M, Maurer M. Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.22];2(S1):S53. Available from: https://jofskin.org/index.php/skin/article/view/299